Crossmark

Potential benefits of GLP-1 receptor agonist in dialysis patients with type 2 diabetes: the need for comprehensive pharmacokinetic and hemodialysis analyses

Crossref DOI link: https://doi.org/10.1186/s12933-024-02543-1

Published Online: 2025-03-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lai, Hsuan-Wen

Chen, Jui-Yi

Wu, Vin-Cent

See, Chun Yin
License Information

Text and Data Mining valid from 2025-03-08

Version of Record valid from 2025-03-08
More Information

Article History

Received: 24 November 2024

Accepted: 10 December 2024

First Online: 8 March 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below